Shares are down in the year to date and 20% off their 52-week high, but analysts see 30% upside ahead for Pfizer.

TOKYO -- Roughly 2.5 million doses of oral COVID-19 medication bought by the Japanese government during the pandemic expired ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Research shows that COVID tends to spike twice annually — once in the winter and once in the summer, and, like past years, ...

If you get COVID-19, one drug, Paxlovid, is the drug of choice. But for some who take it, COVID symptoms return again a few weeks later. Researchers are studying what ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

Symptoms mirror Omicron’s, that is, fever, cough, fatigue, sore throat, and muscle aches. Though India’s Covid response ...

An extremely painful sore throat, often now referred to as “razor blade throat”, is just one of the several symptoms of a new ...

Up to 60 percent of older adults live with persistent muscle pain, but there’s a lot you can do to ease that discomfort.

Q: I used to be a serious exerciser, but now that I am in my late 60s, I find it harder and harder to stay on track. Got any words ...